BRET R ELLIOTT
Allopathic & Osteopathic Physicians|Family Medicine OMAHA, NE NPI 1902396823
Browse related groups: Allopathic & Osteopathic Physicians|Family Medicine NE ABBVIE INC. All categories
General Payments — all program years on this page
$5,174.02
- Category: General Payments
- Program years: PY2020–2024
- Record count: 327
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $1,700.27 across 104 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,700.27 | 104 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $336.29 | 18 |
| PFIZER INC. | $294.11 | 25 |
| Acerta Pharma LLC | $197.85 | 9 |
| Novo Nordisk AS | $186.20 | 11 |
| Amgen Inc. | $132.78 | 10 |
| Biogen, Inc. | $96.08 | 5 |
| Janssen Pharmaceuticals, Inc | $65.90 | 3 |
| Lilly USA, LLC | $63.01 | 4 |
| Bayer HealthCare Pharmaceuticals Inc. | $40.75 | 2 |
| Organon LLC | $40.15 | 2 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $39.47 | 2 |
| Seqirus USA Inc | $27.47 | 1 |
| MAYNE PHARMA COMMERCIAL LLC | $25.37 | 2 |
| SANOFI PASTEUR INC. | $19.47 | 1 |
| Merck Sharp & Dohme Corporation | $19.39 | 1 |
| Azurity Pharmaceuticals, Inc. | $17.05 | 1 |
| Actelion Pharmaceuticals US, Inc. | $15.16 | 1 |
| Xeris Pharmaceuticals, Inc. | $15.02 | 1 |
| Abbott Laboratories | $14.81 | 1 |
| GlaxoSmithKline, LLC. | $14.03 | 1 |
| Daiichi Sankyo Inc. | $13.45 | 1 |
| Exeltis, USA Inc. | $13.36 | 1 |
| Astellas Pharma US Inc | $13.10 | 1 |
By program year
Records — PY2024 (104)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.